Search results
Earnings call: Teva Pharmaceuticals reports growth and pipeline progress By Investing.com
Investing.com· 2 days agoTeva Pharmaceuticals Industries Ltd. (TEVA) held its first quarter 2024 earnings conference call,...
Teva Pharmaceutical Industries Posts Narrower Loss In Q1 - Update
RTT News· 3 days agoTeva Pharmaceutical Industries Ltd. (TEVA) posted a first quarter net loss attributable to Teva of $139 million or $0.12 per share, compared to a net loss of $220 million and $0.20, per share ...
Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Records 50-Day SMA of $13.68 – Knox Daily
Knox Daily· 2 days agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $1,048,119 were sold ...
Why Is Teva Pharmaceutical Stock Trading Higher On Wednesday? - Teva Pharmaceutical Indus...
Benzinga· 3 days agoWednesday, Teva Pharmaceutical Industries Ltd TEVA and Medincell announced results from the efficacy...
Teva Pharmaceutical Industries Ltd DRC Stock Price Today | BVMF T1EV34 - Investing.com Canada
Investing.com· 3 days agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...
Teva and Medincell's schizophrenia drug meets main goal of late-stage study
Reuters· 3 days agoIsrael-based Teva Pharmaceuticals , and French partner Medincell said on Wednesday their injectable...
Q1 2024 Teva Pharmaceutical Industries Ltd Earnings Call Transcr
Guru Focus· 3 days agoMay 08, 2024 / 12:00PM GMTOperator Hello, and welcome to the First Quarter 2024 Teva Pharmaceutical Industries Limited Earnings Conference Call. My name is Alex
Teva Pharmaceutical Industries (TEVA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks via Yahoo Finance· 3 days agoAlthough the revenue and EPS for Teva Pharmaceutical Industries (TEVA) give a sense of how its...
Teva Pharmaceutical’s stock climbs as schizophrenia treatment shows promise
Market Watch· 3 days agoTeva Pharmaceutical Industries stock jumped more than 6% early Wednesday after the company reported...
Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-'749...
Benzinga· 3 days agoThe study met its primary endpoint achieving clinically meaningful and statistically significant reductions across all TEV-‘749 dose groups versus placebo in the Positive and Negative Syndrome Scale (PANSS) total